Live Breaking News & Updates on Patients With Nonmetastatic Prostate|Page 1

Stay updated with breaking news from Patients with nonmetastatic prostate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Approves Enzalutamide for Nonmetastatic Castration-Sensitive Prostate Cancer

The approval makes enzalutamide the first and only androgen receptor-signaling inhibitor approved for the treatment of nonmetastatic castration-sensitive prostate cancer with biochemical recurrence at high risk for metastatic. ....

United States , Ahsan Arozullah , Oncology Development At Astellas , Pfizer Inc , European Medicines Agency , Astellas Pharma Inc , Strategic Innovation , Genesiscare United States , South America , Efficacy Study , Enzalutamide Plus Leuprolide , Patients With Nonmetastatic Prostate , For Papers , Pharmacy Times Oncology , Oncology Development , New England Journal ,